Chat with us

Liquid or soft-gel vs tablet levothyroxine after total thyroidectomy

Journal
World Journal of Clinical Cases, 2026
Design
Systematic review and meta-analysis
Evidence
9 studies, 1,115 participants
Timeline
Accepted 1 April 2026, published 6 June 2026

The question

Patients without a thyroid gland depend completely on levothyroxine, and absorption of the tablet form varies. Newer liquid and soft-gel formulations may be absorbed better, but their benefit after total thyroidectomy was uncertain. The team asked whether these formulations change thyroid function compared with tablets in athyreotic adults.

What the team did

The team searched MEDLINE, Embase, CENTRAL and Scopus from inception to 1 January 2026, and included randomised controlled trials and cohort studies of adults after total thyroidectomy. The primary outcome was serum TSH, with total thyroxine and triiodothyronine as secondary outcomes. The review followed PRISMA 2020, assessed risk of bias with RoB 2 for trials and a separate tool for non-randomised studies, and graded certainty with GRADE.

What they found

Liquid or soft-gel levothyroxine was associated with a significantly lower TSH level than tablets (standardised mean difference −0.91, 95% CI −1.52 to −0.30, P = 0.003). The paper also reports subgroup analyses by malabsorption status and by study design.

The team

Muhammad Farhan led the project with an international team of students and doctors from the UAE, Egypt, Pakistan, the Caribbean and the United States, including first-time authors.

This was one of the first research papers I had the opportunity to contribute to. Looking back, this paper was more than just a publication. It was the beginning of a journey of continuous learning, growth, and discovery.